Henry Ford Cancer-Detroit is a clinical research site located in Detroit, Michigan, United States 48201.
Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.
Henry Ford Cancer-Detroit has participated in 16 clinical trials with 16 currently active.
Therapeutic areas: Gastrointestinal Cancer, Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer.
Sponsors: Henry Ford Health System, TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics), Bindu R Potugari.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Michigan · View every site in Detroit
Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Henry Ford Cancer-Detroit has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Henry Ford Cancer-Detroit has 16 clinical trials on record, with 16 currently active. Their work covers Gastrointestinal Cancer, Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer.
Henry Ford Cancer-Detroit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.